デフォルト表紙
市場調査レポート
商品コード
1265639

非侵襲的出生前検査(NIPT)の世界市場

Non-Invasive Prenatal Testing (NIPT)

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 89 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
非侵襲的出生前検査(NIPT)の世界市場
出版日: 2023年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

非侵襲的出生前検査(NIPT)の世界市場は2030年までに92億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に29億米ドルと推定される非侵襲的出生前検査(NIPT)の世界市場は、2030年までに92億米ドルの改定規模に達し、2022年から2030年にかけてCAGR 15.3%で成長すると予測されます。本レポートで分析したセグメントの一つである消耗品・試薬は、CAGR12.4%を記録し、分析期間終了時には55億米ドルに達すると予測されます。パンデミック後の回復を考慮し、機器分野の成長は、今後8年間のCAGRが21.4%に修正されました。

米国市場は7億9,950万米ドル、中国はCAGR19.5%で成長すると予測

米国の非侵襲的出生前検査(NIPT)市場は、2022年に7億9,950万米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが19.5%となり、2030年には21億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ10.6%と13.4%の成長が予測されています。欧州では、ドイツがCAGR12.1%で成長すると予測されています。

調査対象企業の例

  • Agilent Technologies, Inc.
  • Berry Genetics Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins LifeCodexx GmbH
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Igenomix
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Yourgene Health

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
目次
Product Code: MCP22387

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Non-Invasive Prenatal Testing (NIPT) Market to Reach $9.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Non-Invasive Prenatal Testing (NIPT) estimated at US$2.9 Billion in the year 2022, is projected to reach a revised size of US$9.2 Billion by 2030, growing at aCAGR of 15.3% over the period 2022-2030. Consumables & Reagents, one of the segments analyzed in the report, is projected to record 12.4% CAGR and reach US$5.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 21.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $799.5 Million, While China is Forecast to Grow at 19.5% CAGR

The Non-Invasive Prenatal Testing (NIPT) market in the U.S. is estimated at US$799.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 19.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 13.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Select Competitors (Total 33 Featured) -

  • Agilent Technologies, Inc.
  • Berry Genetics Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins LifeCodexx GmbH
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Igenomix
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Yourgene Health

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Non-Invasive Prenatal Testing (NIPT) - Global Key Competitors Percentage Market Share in 2021 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2021 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Ultrasound Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Ultrasound Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Ultrasound Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Biochemical Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Biochemical Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Biochemical Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cell-free DNA in Maternal Plasma Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cell-free DNA in Maternal Plasma Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cell-free DNA in Maternal Plasma Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Trisomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Microdeletion Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Microdeletion Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Microdeletion Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Non-Invasive Prenatal Testing (NIPT) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Consumables & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • JAPAN
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • CHINA
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • EUROPE
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • FRANCE
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: France 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: France 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • GERMANY
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Italy 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: UK 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Spain 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Spain 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Spain 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Russia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Russia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Russia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Russia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Rest of Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of Europe 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Australia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Australia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Australia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: Australia 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • INDIA
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: India 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: India 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: India 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: India 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: South Korea 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: South Korea 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: South Korea 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: South Korea 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 262: Argentina 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 265: Argentina 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 268: Argentina 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 271: Argentina 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 274: Brazil 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 277: Brazil 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 280: Brazil 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 283: Brazil 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 286: Mexico 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 289: Mexico 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 292: Mexico 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 295: Mexico 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 298: Rest of Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 301: Rest of Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 304: Rest of Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 307: Rest of Latin America 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 310: Middle East 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 313: Middle East 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 316: Middle East 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 319: Middle East 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 322: Middle East 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 325: Iran 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 328: Iran 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 331: Iran 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2014, 2023 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 334: Iran 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 337: Israel 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2014, 2023 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 340: Israel 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR